	US 12,234,481 B2
	Use of exosome derived from decidual natural killer (dNK) cells or dNK cell subset in preparation of drug and auxiliary therapeutic agent for infertility-related diseases
Shi Hu, Shanghai (CN); and Min Ding, Shanghai (CN)
Assigned to PHARCHOICE THERAPEUTICS INC, Shanghai (CN)
Appl. No. 17/426,120
Filed by PHARCHOICE THERAPEUTICS INC, Shanghai (CN)
PCT Filed Sep. 30, 2020, PCT No. PCT/CN2020/119327 § 371(c)(1), (2) Date Jul. 28, 2021, PCT Pub. No. WO2021/103817, PCT Pub. Date Jun. 3, 2021.
Claims priority of application No. 201911178817.7 (CN), filed on Nov. 27, 2019.
Prior Publication US 2022/0096550 A1, Mar. 31, 2022
Int. Cl. A61K 35/17 (2015.01); A61P 15/08 (2006.01); C12N 5/0783 (2010.01)

CPC C12N 5/0646 (2013.01) [A61K 35/17 (2013.01); A61P 15/08 (2018.01); C12N 2509/00 (2013.01)]

10 Claims

1. A method of preparing a drug and an auxiliary therapeutic agent for infertility-related diseases, comprising the step of using an exosome derived from decidual natural killer (dNK) cells or a dNK cell subset.